Innohep, generically known as Tinzaparin, is a type of medication known as a low molecular weight heparin (LMWH). It is primarily used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). This medication works by inhibiting certain factors in the blood clotting process, effectively reducing the ability of blood to form dangerous clots. It is administered through subcutaneous injections, and its dosage may vary depending on the specific condition being treated, the patient's weight, and other individual factors. Innohep is often prescribed in hospital settings but may also be used in outpatient scenarios under careful medical supervision. Like all anticoagulants, it carries a risk of bleeding complications, so monitoring and follow-up are crucial during treatment.